FR2399844A1 - Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes - Google Patents

Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes

Info

Publication number
FR2399844A1
FR2399844A1 FR7823522A FR7823522A FR2399844A1 FR 2399844 A1 FR2399844 A1 FR 2399844A1 FR 7823522 A FR7823522 A FR 7823522A FR 7823522 A FR7823522 A FR 7823522A FR 2399844 A1 FR2399844 A1 FR 2399844A1
Authority
FR
France
Prior art keywords
skeleton
pharmaceutical composition
composition including
cellular walls
microbial cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7823522A
Other languages
English (en)
French (fr)
Other versions
FR2399844B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2399844A1 publication Critical patent/FR2399844A1/fr
Application granted granted Critical
Publication of FR2399844B1 publication Critical patent/FR2399844B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7823522A 1977-08-09 1978-08-09 Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes Granted FR2399844A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (2)

Publication Number Publication Date
FR2399844A1 true FR2399844A1 (fr) 1979-03-09
FR2399844B1 FR2399844B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-08-20

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7823522A Granted FR2399844A1 (fr) 1977-08-09 1978-08-09 Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes

Country Status (15)

Country Link
US (1) US4543253A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5428813A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU526788B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE869610A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1118348A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH643459A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2834893A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK153443C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI65370C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2399844A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2002229B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU179726B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1098381B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7808337A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE447629B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
CN1230184C (zh) * 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
JP4726485B2 (ja) * 2002-08-02 2011-07-20 大日本住友製薬株式会社 細菌細胞壁骨格成分製剤
JP5041279B2 (ja) * 2004-04-22 2012-10-03 株式会社 Ｍｂｒ 細菌細胞壁骨格成分を含有する製剤
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2268531A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-04-25 1975-11-21 Anvar
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
BE830486A (fr) * 1974-06-20 1975-12-22 Fractions mycobacteriennes utilisables comme agent antiinfectieux, et procede de preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2268531A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-04-25 1975-11-21 Anvar
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/76 *

Also Published As

Publication number Publication date
SE7808414L (sv) 1979-02-10
BE869610A (fr) 1979-02-08
AU3879178A (en) 1980-02-14
NL7808337A (nl) 1979-02-13
AU526788B2 (en) 1983-02-03
DK153443B (da) 1988-07-18
HU179726B (en) 1982-11-29
DK153443C (da) 1988-12-05
FI782442A7 (fi) 1979-02-10
FI65370C (fi) 1984-05-10
GB2002229B (en) 1982-05-26
DE2834893A1 (de) 1979-02-22
SE447629B (sv) 1986-12-01
JPS5428813A (en) 1979-03-03
GB2002229A (en) 1979-02-21
DK352578A (da) 1979-02-10
DE2834893C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-08-27
FI65370B (fi) 1984-01-31
JPS631291B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-01-12
CA1118348A (en) 1982-02-16
FR2399844B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-08-20
IT7826609A0 (it) 1978-08-08
CH643459A5 (de) 1984-06-15
US4543253A (en) 1985-09-24
IT1098381B (it) 1985-09-07

Similar Documents

Publication Publication Date Title
DK0690856T3 (da) Antitumorforbindelser, farmaceutiske præparater, fremgangsmåder til fremstilling deraf og til behandling
FR2399844A1 (fr) Composition pharmaceutique solidifiee comprenant un squelette de parois cellulaires microbiennes
ES472661A1 (es) Procedimiento para la preparacion de nuevos nitroimidazoles
AP2000002013A0 (en) 2-(Purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives.
ES435950A1 (es) Procedimiento de preparacion de acidos 4-aril-4-oxo-2-me- til-2-butenoicos y sus derivados amidicos.
ES462288A1 (es) Procedimiento para la obtencion de azabiciclohexanonas sus- tituidas.
ATE99931T1 (de) Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung.
ES469874A1 (es) Procedimiento para la preparacion de compuestos complejos demetales alcalinos
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
ES486279A1 (es) Procedimiento para la obtencion de hidroxipropil-triazoles
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
FR2363329A1 (fr) Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
YU122290A (sh) Jedinjenja indenoindola i
ES465897A1 (es) Procedimiento para la preparacion de halogenuros de ditieni-lalcohilo.
ES465313A1 (es) Procedimiento para la obtencion de derivados de naftiridina.
FR2409999A1 (fr) Produits de degradation de l'antibiotique appele rubradirine et de sa forme b, leur procede de preparation et leur application comme agents antibacteriens
ATE769T1 (de) Triazolylderivate, verfahren zu ihrer herstellung sowie diese enthaltende mittel zur beeinflussung des pflanzenwachstums.
ES449699A1 (es) Un procedimiento para la preparacion de una composicion an- tialergica.
SE7701213L (sv) Sett att framstella nya trifenylalkenderivat
ES475345A1 (es) Un procedimiento para la preparacion de diclorovinilciclobu-tanonas
FR2406444A1 (fr) Nouveau medicament contenant un derive du psoralene
ES475346A1 (es) Un procedimiento para la preparacion de cloruros de acido butirico halogenados
ES8205414A1 (es) Un procedimiento de preparacion de derivados de tiazol